Market Cap 18.61M
Revenue (ttm) 15.03M
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.12%
Debt to Equity Ratio 3.45
Volume 76,000
Avg Vol 199,640
Day's Range N/A - N/A
Shares Out 8.99M
Stochastic %K 49%
Beta 6.88
Analysts Sell
Price Target $5.83

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Address:
7921 Southpark Plaza, Suite 210, Littleton, United States
Giovannirs3
Giovannirs3 Dec. 4 at 9:27 PM
$VVOS 👌👇
0 · Reply
TickerBR
TickerBR Dec. 4 at 9:19 PM
$VVOS takes time and money, but we’ve got a real business solving real life problems, wi tu patents and FDA cleared plus reimbursement. I am super
0 · Reply
Are_You_Experienced
Are_You_Experienced Dec. 4 at 8:10 PM
$VVOS Pricing adjustments (down) and operating expenses increased 74%, plus difficulty filling SO positions, especially RN's. Typical startup issues.
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 7:33 PM
$VVOS -99,99%.
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 7:20 PM
$VVOS 👇
0 · Reply
Are_You_Experienced
Are_You_Experienced Dec. 4 at 4:30 PM
$VVOS Here's the biggest reason for the current sp. They have a bit to go before becoming CFP. " Nine-month revenue totaled $13.6 million, up from $11.3 million in the prior year. However, gross margins dipped slightly to 58% due to pricing adjustments, and operating expenses rose 74% year-over-year to $8.7 million, resulting in a Q3 net loss of $5.4 million and an operating loss of $4.7 million."
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 4:17 PM
$VVOS 👇
0 · Reply
oklnd
oklnd Dec. 4 at 2:49 PM
$VVOS next $1.7
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 2:42 PM
$VVOS 👌
0 · Reply
JohnnyBean
JohnnyBean Dec. 4 at 1:50 PM
$VVOS New Vivos position listed 12/3/25:
0 · Reply
Latest News on VVOS
Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript

Aug 22, 2025, 3:08 PM EDT - 3 months ago

Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 15, 2025, 7:31 PM EDT - 7 months ago

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 12:18 AM EDT - 8 months ago

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript


Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Closes $4 Million Private Placement


Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Reverse Stock Split


Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Oct 11, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine


Giovannirs3
Giovannirs3 Dec. 4 at 9:27 PM
$VVOS 👌👇
0 · Reply
TickerBR
TickerBR Dec. 4 at 9:19 PM
$VVOS takes time and money, but we’ve got a real business solving real life problems, wi tu patents and FDA cleared plus reimbursement. I am super
0 · Reply
Are_You_Experienced
Are_You_Experienced Dec. 4 at 8:10 PM
$VVOS Pricing adjustments (down) and operating expenses increased 74%, plus difficulty filling SO positions, especially RN's. Typical startup issues.
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 7:33 PM
$VVOS -99,99%.
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 7:20 PM
$VVOS 👇
0 · Reply
Are_You_Experienced
Are_You_Experienced Dec. 4 at 4:30 PM
$VVOS Here's the biggest reason for the current sp. They have a bit to go before becoming CFP. " Nine-month revenue totaled $13.6 million, up from $11.3 million in the prior year. However, gross margins dipped slightly to 58% due to pricing adjustments, and operating expenses rose 74% year-over-year to $8.7 million, resulting in a Q3 net loss of $5.4 million and an operating loss of $4.7 million."
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 4:17 PM
$VVOS 👇
0 · Reply
oklnd
oklnd Dec. 4 at 2:49 PM
$VVOS next $1.7
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 2:42 PM
$VVOS 👌
0 · Reply
JohnnyBean
JohnnyBean Dec. 4 at 1:50 PM
$VVOS New Vivos position listed 12/3/25:
0 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 1:11 PM
$VVOS 🤣👌
0 · Reply
kemsma62
kemsma62 Dec. 4 at 12:09 PM
$VVOS Still optimistic here, but weird things are going on! It’s a mix of market-maker manipulation, dark-pool shorting, and dilution. And who, for Christ’s sake, buys two shares?
2 · Reply
Giovannirs3
Giovannirs3 Dec. 4 at 8:57 AM
$VVOS 👇
0 · Reply
Giovannirs3
Giovannirs3 Dec. 3 at 9:43 PM
$VVOS ❤️
0 · Reply
AbuUmamah
AbuUmamah Dec. 3 at 7:46 PM
$VVOS monthly chart shows triple bottom..strong chart pattern for major reversal..good to buy n & hold until next year..
0 · Reply
Giovannirs3
Giovannirs3 Dec. 3 at 7:04 PM
$VVOS 👇
0 · Reply
Bumpkaboo
Bumpkaboo Dec. 3 at 6:33 PM
$VVOS Sell now to harvest loss credit. Buy back after Q1 ER update on the long dragged cash flow pooptive. Oops, I mean positive. 🥲
0 · Reply
YFZ450
YFZ450 Dec. 3 at 4:06 PM
$VVOS 7 months absolutely straight down is wild... i wish companies like this would just throw in the towel instead of rob people
0 · Reply
Giovannirs3
Giovannirs3 Dec. 3 at 3:47 PM
$VVOS ❤️👍👇
0 · Reply
Giovannirs3
Giovannirs3 Dec. 3 at 3:47 PM
$VVOS 👇👇
0 · Reply
Giovannirs3
Giovannirs3 Dec. 3 at 3:47 PM
$VVOS ❤️👍
0 · Reply
PaddyIce87
PaddyIce87 Dec. 3 at 3:47 PM
$VVOS $2 has broken, $1LAND is here. Huntsman !?!?
1 · Reply